How Health Network Laboratories is Advancing Healthcare through Innovation
Healthcare is an industry that is constantly evolving, and Health Network Laboratories (HNL) is leading the way in advancements through innovation. HNL is a regional clinical laboratory that is dedicated to providing top-quality laboratory services to the healthcare community. Their mission is to improve patient outcomes by delivering timely, accurate, and reliable testing services.
Background
Founded in 1998, Health Network Laboratories has been committed to enhancing the quality of healthcare in America. The laboratory has since grown to become one of the largest independent full-service laboratories in the country. With over 60 facilities throughout Pennsylvania and New Jersey, HNL offers a broad range of clinical tests, anatomical pathology, and drug testing services. HNL’s state-of-the-art facilities and advanced laboratory technologies enable them to deliver fast, accurate, and precise test results.
Testing Services
HNL provides a broad range of testing services, including blood tests, molecular testing, drug testing, and pathology. The laboratory offers both routine and advanced tests that utilize various techniques and instruments, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), next-generation sequencing (NGS), and flow cytometry, among others. Notably, HNL is renowned for its COVID-19 testing services and was one of the first labs to offer testing for the virus in the early days of the pandemic. HNL’s testing services have played an essential role in helping healthcare providers diagnose and treat diseases accurately and timely.
Innovation
Innovation is at the core of HNL’s operations. HNL invests heavily in research and development to advance laboratory testing capabilities and efficacy. The laboratory regularly collaborates with leading scientists, physicians, and healthcare organizations to identify new testing methods and technologies that deliver better patient outcomes. For example, HNL recently adopted liquid biopsy testing for non-invasive and early-stage cancer detection. Liquid biopsies involve analyzing a patient’s blood or urine for tumor biomarkers, which can inform cancer diagnosis and drug treatment. Liquid biopsies are less invasive than traditional tissue biopsies and can help patients start cancer treatment earlier, leading to better outcomes.
Conclusion
Health Network Laboratories is a leading regional laboratory that is advancing healthcare through innovative testing services. Their investment in research and development has yielded several breakthroughs that have improved patient outcomes. Their state-of-the-art facilities, advanced technologies, and collaborations with leading healthcare providers have positioned them at the forefront of clinical laboratory testing. HNL’s mission is to help healthcare providers deliver better patient outcomes, and their dedication and innovative approach to laboratory testing services have made them a valuable player in the healthcare industry.
